MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$160,995K
(-82.87%↓ Y/Y)
Interest income, net
$29,931K
(12.42%↑ Y/Y)
Net loss and
comprehensive loss
-$160,995K
(-82.87%↓ Y/Y)
Total other income,
net
$29,779K
(11.84%↑ Y/Y)
Commercial And Development
Revenue
$3,234K
License And
Collaboration Revenue
$806K
Other (expense)
income, net
-$152K
(-5166.67%↓ Y/Y)
Loss from operations
-$190,774K
(-66.37%↓ Y/Y)
Total revenues
$4,040K
(254.70%↑ Y/Y)
Total operating costs
and expenses
$194,814K
Research and development
$116,641K
(42.07%↑ Y/Y)
General and
administrative
$73,526K
(118.16%↑ Y/Y)
Cost of sales
$4,647K
Back
Back
Income Statement
source: myfinsight.com
CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON)